Neuroscience Institute Clinical Trials

A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

Study ID:

NEU24048 (STK-001-DS-301)

Principal Investigator:

Matt S Lallas, MD

View Study Details

A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult Subjects

Study ID:

NEU99205 (BT005)

Principal Investigator:

John Ragheb, MD

View Study Details

A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

Study ID:

NEU24088 (LP352-302)

Principal Investigator:

Matt S Lallas, MD

View Study Details

A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)

Study ID:

NEU24061 (LP352-301)

Principal Investigator:

Matt S Lallas, MD

View Study Details

A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

Study ID:

NEU24007 (EP0224)

Principal Investigator:

Anuj Jayakar, MD

View Study Details

Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)

Study ID:

NEU23134 (BT016)

Principal Investigator:

Toba N Niazi, MD

View Study Details

Focal Cerebral Arteriopathy Steroid Trial (FOCAS)

Study ID:

NEU23170 (FOCAS)

Principal Investigator:

Anuj Jayakar, MD

View Study Details

REVEAL: A Phase 3 Study of ION582 in Angelman Syndrome